Summary:
NSE, Lupin, MCX, Metropolis Healthcare and Lloyds Metals are among the stocks in focus on November 4 after reporting Q2FY27 results. Indian Energy Exchange and Allcargo Terminals shared October updates, while JNK India and others announced corporate developments for Wednesday's session.
Which stocks are in focus today?
Several companies announced their September quarter results, business updates and significant corporate developments, making them important stocks to watch in the November 4 trading session. The National Stock Exchange of India (NSE), Lupin, Metropolis Healthcare, Lloyds Metals and Energy, Multi Commodity Exchange of India (MCX), Awfis Space Solutions, Aarti Drugs, Global Health and Vijaya Diagnostic Centre reported their Q2FY27 financial results. Meanwhile, Indian Energy Exchange and Allcargo Terminals released their October business updates.
What are the key developments in these stocks?
| Company | Announcement | Key detail |
| NSE | Q2FY27 results | Net profit up 22.8% to ₹2,577.6 crore |
| Lupin | Q2FY27 results | Net profit down 22.2%; revenue up 11.1% |
| Metropolis Healthcare | Q2FY27 results | Net profit up 42.7% |
| Lloyds Metals and Energy | Q2FY27 results and board approvals | Net profit up 88%; 360 MW thermal power plant approved |
| MCX | Q2FY27 results | Net profit up 130.2% |
| Awfis Space Solutions | Q2FY27 results | Net profit up 92.8% |
| Aarti Drugs | Q2FY27 results | Net profit up 83.2% |
| Global Health (Medanta) | Q2FY27 results | Net profit up 39.3% |
| Vijaya Diagnostic Centre | Q2FY27 results | Net profit up 37.4% |
| Indian Energy Exchange | October business update | Electricity traded volume up 16.5% |
| Allcargo Terminals | October business update | Volumes up 4% YoY and 10% MoM |
| JNK India | Order win | Order worth ₹300–600 crore |
| Highway Infrastructure | Letter of Acceptance | Order worth ₹198.3 crore |
| Hindustan Zinc | Product launch | Launched VedAZ and VedAyush |
Alongside company-specific earnings announcements, business updates and corporate developments, market participants will also monitor the broader market trend during Wednesday's trading session. The Nifty 50 gained 370.05 points to close at 23,810.85 on November 3, moving above its 61.8% Fibonacci retracement level. Read our Nifty prediction for November 4 for the latest technical outlook, including key support and resistance levels, EMA positioning and RSI indicators.
| Company | Net profit YoY | Revenue YoY |
| NSE | 22.80% | 10.60% |
| Lupin | -22.20% | 11.10% |
| Metropolis Healthcare | 42.70% | 15.80% |
| Lloyds Metals and Energy | 88.00% | 55.30% |
| MCX | 130.20% | 113.70% |
| Awfis Space Solutions | 92.80% | 19.60% |
| Aarti Drugs | 83.20% | 26.60% |
| Global Health | 39.30% | 33.60% |
| Vijaya Diagnostic Centre | 37.40% | 26.70% |
Stocks in Focus Today: Q2FY27 Results and Key Company Updates
National Stock Exchange of India: The exchange reported a 22.8% year-on-year increase in consolidated net profit to ₹2,577.6 crore in Q2FY27, compared with ₹2,098.5 crore in the corresponding quarter last year. Revenue increased 10.6% to ₹4,066.8 crore from ₹3,676.8 crore.
Lupin: The pharmaceutical company reported a 22.2% decline in consolidated net profit to ₹1,155.3 crore against ₹1,484.8 crore in the year-ago quarter. However, revenue grew 11.1% to ₹7,827.3 crore from ₹7,047.5 crore.
Metropolis Healthcare: The diagnostic services provider posted a 42.7% jump in consolidated net profit to ₹75.5 crore compared with ₹52.9 crore. Revenue increased 15.8% to ₹496.8 crore from ₹429.2 crore.
Lloyds Metals and Energy: The company reported an 88% surge in consolidated net profit to ₹1,045.6 crore against ₹556 crore. Revenue jumped 55.3% to ₹5,672.5 crore from ₹3,652.1 crore. Additionally, its board approved setting up a 360 MW thermal power plant at Konsari, Maharashtra. The board also approved an investment of up to 30% stake in renewable energy projects for procuring 168 MW of power through the captive route.
Multi Commodity Exchange of India: MCX reported a 130.2% spike in consolidated net profit to ₹454.6 crore compared with ₹197.5 crore. Revenue more than doubled, increasing 113.7% to ₹799.7 crore from ₹374.2 crore.
Awfis Space Solutions: Consolidated net profit jumped 92.8% to ₹30.8 crore against ₹16 crore, while revenue grew 19.6% to ₹438.7 crore from ₹366.9 crore.
Aarti Drugs: The pharmaceutical company posted an 83.2% surge in consolidated net profit to ₹82.9 crore compared with ₹45.3 crore. Revenue increased 26.6% to ₹826.2 crore from ₹652.8 crore.
Global Health (Medanta): Consolidated net profit grew 39.3% to ₹220.7 crore against ₹158.4 crore. Revenue jumped 33.6% to ₹1,469 crore from ₹1,099.3 crore.
Vijaya Diagnostic Centre: The company reported a 37.4% increase in consolidated net profit to ₹59.5 crore compared with ₹43.3 crore. Revenue increased 26.7% to ₹255.4 crore from ₹201.6 crore.
October Business Updates on November 04 : IEX and Allcargo Terminals
Indian Energy Exchange: Electricity traded volume increased 16.5% year-on-year to 13.1 billion units (BU) in October. Real-time market volume rose 23.7% to 5.7 BU, while day-ahead market volume declined 3.8% to 4,508 million units (MU).
Allcargo Terminals: Total volumes increased 4% year-on-year and 10% month-on-month to 68,200 twenty-foot equivalent units (TEUs) in October.
Major Corporate Developments on November 04: Orders, Product Launches and Approvals
Lupin: The company announced the launch of Raltegravir Tablets USP, 600 mg, in the US after receiving approval from the US Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA). The tablets are indicated, in combination with other antiretroviral agents, for treating HIV-1 infection in adult patients. Lupin is the exclusive first-to-file applicant and is eligible for 180-day generic drug exclusivity.
JNK India: The company secured a major order worth ₹300–600 crore from JNK Global, Korea. The order involves the design and engineering, supply and transportation of a heater package for an overseas project in Nigeria.
Highway Infrastructure: The company received a Letter of Acceptance (LOA) worth ₹198.3 crore from the Central Public Works Department (CPWD). The contract covers planning, design and construction of residential and non-residential infrastructure under Phase I of the establishment of the CISF 12th Reserve Battalion at Village Jamunia Talab, Madhya Pradesh, on an EPC Mode-I basis.
Hindustan Zinc: The company launched two new value-added zinc products, VedAZ and VedAyush. These next-generation zinc alloys have been developed for the galvanising industry.
Stocks to Watch Today November 04: Key Developments at a Glance
Investors will track these companies following their quarterly earnings announcements, monthly operational updates and order wins. While several companies reported strong year-on-year profit growth, Lupin recorded a decline in profitability despite revenue growth. Corporate developments at Lloyds Metals, JNK India, Highway Infrastructure and Hindustan Zinc will also remain in focus.
Disclaimer: The article is for informational purposes only and not investment advice.
